Dong Wha Pharm Overview

  • Year Founded
  • 1897

Year Founded

  • Status
  • Public

  • Employees
  • 846

Employees

  • Stock Symbol
  • 000020

Stock Symbol

  • Investments
  • 8

  • Share Price
  • $3.63
  • (As of Friday Closing)

Dong Wha Pharm General Information

Description

Dongwha Pharm Co Ltd is engaged in manufacturing and selling pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/ respiratory system, muscle relaxant/musculoskeletal system, nervous system, and dermatological/urinary system among several other products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Building 1897, 20 Seosomun-ro 9-gil, Jung-gu
  • Seoul, Jung 04516
  • South Korea
+82
Primary Industry
Pharmaceuticals
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • Building 1897, 20 Seosomun-ro 9-gil, Jung-gu
  • Seoul, Jung 04516
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dong Wha Pharm Stock Performance

As of 20-Nov-2026, Dong Wha Pharm’s stock price is $3.63. Its current market cap is $101M with 27.7M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.63 $3.73 $3.03 - $5.08 $101M 27.7M 239K $0.44

Dong Wha Pharm Financials Summary

As of 30-Sep-2026, Dong Wha Pharm has a trailing 12-month revenue of $357M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 186,316 206,498 162,669 150,523
Revenue 357,086 348,803 340,708 276,193
EBITDA 26,369 21,976 20,006 36,641
Net Income 12,237 6,103 4,077 20,986
Total Assets 480,144 445,947 420,670 433,405
Total Debt 87,485 82,232 65,846 36,549
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Dong Wha Pharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dong Wha Pharm‘s full profile, request access.

Request a free trial

Dong Wha Pharm Patents

Dong Wha Pharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026139915-A1 Novel carboxamide derivative compound and pharmaceutical composition comprising same Pending 26-Dec-2024
WO-2025053515-A1 Cosmetic composition containing culture solutions of fusarium corneum and streptococcus sp. strains and use thereof Inactive 04-Sep-2023
WO-2025053514-A1 Reverse-phase liposome containing culture medium of fusidium corneum and use thereof Inactive 04-Sep-2023
AU-2024332189-A1 Novel lactic acid bacteria and use thereof Pending 01-Sep-2023
EP-4772609-A1 Novel lactic acid bacteria and use thereof Pending 01-Sep-2023 C12N1/205
To view Dong Wha Pharm’s complete patent history, request access »

Dong Wha Pharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dong Wha Pharm Investments & Acquisitions (8)

Dong Wha Pharm’s most recent deal was a Corporate Asset Purchase with Celltrion (4 Types of Over the Counter Drugs). The deal was made on 19-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Celltrion (4 Types of Over the Counter Drugs) 19-Jan-2024 Corporate Asset Purchase Buildings and Property
Trung Son Alpha 03-Aug-2023 Merger/Acquisition Specialty Retail
Fitpet 21-Mar-2023 Later Stage VC Other Services (B2C Non-Financial)
HAII 23-Nov-2022 Later Stage VC Other Healthcare Technology Systems
ORGANOID SCIENCES 13-Jan-2022 Early Stage VC Drug Discovery
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Dong Wha Pharm ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Dong Wha Pharm’s complete esg history, request access »

Dong Wha Pharm Exits (1)

Dong Wha Pharm’s most recent exit was on 01-Oct-2018 from Next Biomedical. The exit was categorized as with 6 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Next Biomedical 01-Oct-2018 Completed
  • 6 buyers
To view Dong Wha Pharm’s complete exits history, request access »

Dong Wha Pharm Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Medyssey Jecheon, South Korea 2003
Trung Son Alpha Can Tho, Vietnam 1997

Dong Wha Pharm FAQs

  • When was Dong Wha Pharm founded?

    Dong Wha Pharm was founded in 1897.

  • Where is Dong Wha Pharm headquartered?

    Dong Wha Pharm is headquartered in Seoul, South Korea.

  • What is the size of Dong Wha Pharm?

    Dong Wha Pharm has 846 total employees.

  • What industry is Dong Wha Pharm in?

    Dong Wha Pharm’s primary industry is Pharmaceuticals.

  • Is Dong Wha Pharm a private or public company?

    Dong Wha Pharm is a Public company.

  • What is Dong Wha Pharm’s stock symbol?

    The ticker symbol for Dong Wha Pharm is 000020.

  • What is the current stock price of Dong Wha Pharm?

    As of 20-Nov-2026 the stock price of Dong Wha Pharm is $3.63.

  • What is the current market cap of Dong Wha Pharm?

    The current market capitalization of Dong Wha Pharm is $101M.

  • What is Dong Wha Pharm’s current revenue?

    The trailing twelve month revenue for Dong Wha Pharm is $357M.

  • What is Dong Wha Pharm’s annual earnings per share (EPS)?

    Dong Wha Pharm’s EPS for 12 months was $0.44.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process